|
1
|
Suzuki N, Hazama S, Ueno T, Matsui H,
Shindo Y, Iida M, Yoshimura K, Yoshino S, Takeda K and Oka M: A
phase I clinical trial of vaccination with KIF20A-derived peptide
in combination with gemcitabine for patients with advanced
pancreatic cancer. J Immunother. 37:36–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ciuleanu TE, Pavlovsky AV, Bodoky G, Garin
AM, Langmuir VK, Kroll S and Tidmarsh GT: A randomised Phase III
trial of glufosfamide compared with best supportive care in
metastatic pancreatic adenocarcinoma previously treated with
gemcitabine. Eur J Cancer. 45:1589–1596. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao H, Yang G, Wang D, Yu X, Zhang Y, Zhu
J, Ji Y, Zhong B, Zhao W, Yang Z and Aziz F: Concurrent gemcitabine
and high-intensity focused ultrasound therapy in patients with
locally advanced pancreatic cancer. Anticancer Drugs. 21:447–452.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qing SW, Ju XP, Cao YS and Zhang HJ: Dose
escalation of Stereotactic Body Radiotherapy (SBRT) for locally
advanced unresectable pancreatic cancer patients with CyberKnife:
protocol of a phase I study. Radiat Oncol. 12:62017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pelzer U, Schwaner I, Stieler J, Adler M,
Seraphin J, Dörken B, Riess H and Oettle H: Best supportive care
(BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF)
plus BSC in patients for second-line advanced pancreatic cancer: A
phase III-study from the German CONKO-study group. Eur J Cancer.
47:1676–1681. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li Y, Wang Y, Li L, Kong R1, Pan S1, Ji L,
Liu H, Chen H and Sun B: Hyperoside induces apoptosis and inhibits
growth in pancreatic cancer via Bcl-2 family and NF-κB signaling
pathway both in vitro and in vivo. Tumour Biol. 37:7345–7355. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lindqvist LM and Vaux DL: BCL2 and related
prosurvival proteins require BAK1 and BAX to affect autophagy.
Autophagy. 10:1474–1475. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Carter BZ, Mak PY, Mak DH, Ruvolo VR,
Schober W, McQueen T, Cortes J, Kantarjian HM, Champlin RE,
Konopleva M and Andreeff M: Synergistic effects of p53 activation
via MDM2 inhibition in combination with inhibition of Bcl-2 or
Bcr-Abl in CD34+ proliferating and quiescent chronic myeloid
leukemia blast crisis cells. Oncotarget. 6:30487–30499. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martinez-Bosch N, Fernandez-Zapico ME,
Navarro P and Yelamos J: Poly(ADP-Ribose) polymerases: New players
in the pathogenesis of exocrine pancreatic diseases. Am J Pathol.
186:234–241. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chakrabarti G, Moore ZR, Luo X, Ilcheva M,
Ali A, Padanad M, Zhou Y, Xie Y, Burma S, Scaglioni PP, et al:
Targeting glutamine metabolism sensitizes pancreatic cancer to
PARP-driven metabolic catastrophe induced by ss-lapachone. Cancer
Metab. 3:122015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lohse I, Kumareswaran R, Cao P, Pitcher B,
Gallinger S, Bristow RG and Hedley DW: Effects of combined
treatment with ionizing radiation and the PARP inhibitor olaparib
in BRCA mutant and wild type patient-derived pancreatic cancer
xenografts. PLoS One. 11:e01672722016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Temiz P, Akkaş G, Neşe N, Uğur Duman F,
Karakaş C and Erhan Y: Determination-of apoptosis and cell cycle
modulators (p16, p21, p27, p53, BCL-2, Bax, BCL-xL and cyclin D1)
in thyroid follicular carcinoma, follicular adenoma and adenomatous
nodules via a tissue microarray method. Turk J Med Sci. 45:865–871.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Castrogiovanni C, Vandaudenard M,
Waterschoot B, De Backer O and Dumont P: Decrease of mitochondrial
p53 during late apoptosis is linked to its dephosphorylation on
serine 20. Cancer Biol Ther. 16:1296–1307. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hill R, Rabb M, Madureira PA, Clements D,
Gujar SA, Waisman DM, Giacomantonio CA and Lee PW:
Gemcitabine-mediated tumour regression and p53-dependent gene
expression: Implications for colon and pancreatic cancer therapy.
Cell Death Dis. 4:e7912013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deben C, Lardon F, Wouters A, Op de Beeck
K, Van Den Bossche J, Jacobs J, van der Steen N, Peeters M, Rolfo
C, Deschoolmeester V and Pauwels P: APR-246 (PRIMA-1 (MET))
strongly synergizes with AZD2281 (olaparib) induced PARP inhibition
to induce apoptosis in non-small cell lung cancer cell lines.
Cancer Lett. 375:313–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu C, Wu A, Zhu H, Fang H, Xu L, Ye J and
Shen J: Melatonin is involved in the apoptosis and necrosis of
pancreatic cancer cell line SW-1990 via modulating of Bcl-2/Bax
balance. Biomed Pharmacother. 67:133–139. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Z, Wild C, Ding Y, Ye N, Chen H, Wold
EA and Zhou J: BH4 domain of Bcl-2 as a novel target for cancer
therapy. Drug Discov Today. 21:989–996. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Laulier C and Lopez BS: The secret life of
Bcl-2: Apoptosis-independent inhibition of DNA repair by Bcl-2
family members. Mutat Res. 751:247–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hao W, Wang S and Zhou Z: Tubeimoside-1
(TBMS1) inhibits lung cancer cell growth and induces cells
apoptosis through activation of MAPK-JNK pathway. Int J Clin Exp
Pathol. 8:12075–12083. 2015.PubMed/NCBI
|
|
20
|
Kvansakul M and Hinds MG: The Bcl-2
family: Structures, interactions and targets for drug discovery.
Apoptosis. 20:136–150. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen H, Yang X, Feng Z, Tang R, Ren F, Wei
K and Chen G: Prognostic value of Caspase-3 expression in cancers
of digestive tract: A meta-analysis and systematic review. Int J
Clin Exp Med. 8:10225–10234. 2015.PubMed/NCBI
|
|
22
|
Liu SY, Liang QJ, Lin TX, Fan XL, Liang Y,
Heemann U and Li Y: Lipopolysaccharide-enhanced early proliferation
of insulin secreting NIT-1 cell is associated with nuclear
factor-kappaB-mediated inhibition of caspase 3 cleavage. Chin Med J
(Engl). 124:3652–3656. 2011.PubMed/NCBI
|
|
23
|
Tang D, Gao J, Wang S, Yuan Z, Ye N, Chong
Y, Xu C, Jiang X, Li B, Yin W, et al: Apoptosis and anergy of T
cell induced by pancreatic stellate cells-derived galectin-1 in
pancreatic cancer. Tumour Biol. 36:5617–5626. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu F, Jiang N, Xiao ZY, Cheng JP, Mei YZ,
Zheng P, Wang L, Zhang XR, Zhou XB, Zhou WX and Zhang YX: Effects
of poly(ADP-ribose) polymerase-1 (PARP-1) inhibition on sulfur
mustard-induced cutaneous injuries in vitro and in vivo. PeerJ.
4:e18902016. View Article : Google Scholar : PubMed/NCBI
|
